After analyzing the correlation between different genotypes and adverse reactions of anlotinib, for all 20 of the SNPs, only the mutations of CYP2C19-rs3814637 and -rs11568732 genotypes were significantly associated with the occurrence of hypertension and hemoptysis (peripheral lung cancer) in the study population. This evidence concerns the gene CYP2C19 and Hemoptysis.